Leadless Pacemaker Successfully Implanted in a Patient Post-Tricuspid Valve Replacement Following Cardiac Tumor Resection: A Case Study and Review of Existing Literature - Takeaways - MDSpire

Leadless Pacemaker Successfully Implanted in a Patient Post-Tricuspid Valve Replacement Following Cardiac Tumor Resection: A Case Study and Review of Existing Literature

  • By

  • Qi Zou

  • Peng Chang

  • Cheng Jiang

  • Pengyang Lin

  • Shougang Sun

  • October 28, 2025

  • 0 min

Share

  • 1

    Tricuspid valve replacement is necessary when repair is not feasible due to severe damage, often leading to cardiac conduction dysfunction.

  • 2

    The Medtronic leadless pacemaker, Micra, offers a safe alternative for patients unable to receive conventional pacemakers due to various risks.

  • 3

    A 49-year-old female patient developed advanced AV block after tricuspid valve replacement and cardiac tumor resection, necessitating leadless pacemaker implantation.

  • 4

    Leadless pacemaker implantation resulted in stable heart rhythm and improved quality of life for the patient with third-degree AV block.

  • 5

    Leadless pacemakers reduce complications associated with conventional devices, such as infections and lead-induced tricuspid regurgitation.

Original Source(s)

Leadless Pacemaker Successfully Implanted in a Patient Post-Tricuspid Valve Replacement Following Cardiac Tumor Resection: A Case Study and Review of Existing Literature

  • by Qi Zou, Peng Chang, Cheng Jiang, Pengyang Lin, Shougang Sun

  • October 28, 2025

Related Content

Clinical Spectrum, independent risk factors, and treatment outcomes of pediatric arrhythmias: a multicenter retrospective analysis in Xinjiang

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

Switching Anticoagulants After Breakthrough Stroke May Not Improve Outcomes

Registry-based analysis found no short-term advantage to changing therapy following ischemic stroke in patients with atrial fibrillation